glp-1 drugs market dynamics 2025 Trends and Global Forecasts Report 2025: A GLP-1 Receptor Agonist Market Size,

April 14, 2026

13 The median expected protection we determined for GLP-1 receptor agonistswhich exceeds 18 yearsis the highest yet reported for drug-device combinations

Similarily, GLP-1R-mediated suppression of NF-B p65 was also able to modulate neuropathic pain-induced neuroinflammation and improve recognition memory dysfunction (64)

Their long-term risk profile is still unknown

If you have an Ozempic injury you want to report, you can learn more about submitting a Medwatch Voluntary Report here Studies Linking Ozempic and Severe Injuries Multiple studies have been published linking Ozempic and other GLP-1 receptor agonists to severe injuries such as those reported by patients nationwide